Company profile for Sumitomo

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

To broadly contribute to society through value creation based on innovative research and development activities for the betterment of healthcare and fuller lives of people worldwide To contribute to healthcare and people's well-being based upon the principles of patient-oriented management and innovative research To continuously strive to maximize corporate value through constant business development and to fulfill sharehold...
To broadly contribute to society through value creation based on innovative research and development activities for the betterment of healthcare and fuller lives of people worldwide To contribute to healthcare and people's well-being based upon the principles of patient-oriented management and innovative research To continuously strive to maximize corporate value through constant business development and to fulfill shareholder expectations To create an environment in which employees can fulfill their potential and increase their creativity To maintain the trust of society and to contribute to the realization of a better global environment

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Japan
Address
Address
Yubinbango 100-8601 Otemachi, Chiyoda-ku, Tokyo chome No. 3 No. 2 Otemachi Pla...
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250701793878/en/AN-Venture-Partners-Announces-Final-Close-of-%24200M-Fund-I

BUSINESSWIRE
02 Jul 2025

https://www.fiercepharma.com/marketing/power-couple-peetes-team-promote-sumitomos-gemtesa

FIERCE PHARMA
01 Jul 2025

https://www.fiercepharma.com/pharma/japans-marubeni-takes-sumitomos-asia-pharma-business-make-new-company-deal-worth-300m

FIERCE PHARMA
03 Apr 2025

https://www.biospectrumasia.com/news/25/25470/sumitomo-to-market-johnson-johnsons-schizophrenia-drug-in-japan.html

BIOSPECTRUM
21 Jan 2025

https://www.fiercepharma.com/marketing/sumitomo-brings-together-gemtesa-go-getters-discuss-overactive-bladder-symptoms

FIERCE PHARMA
04 Dec 2024

https://www.prnewswire.com/news-releases/joint-venture-company-established-for-incubation-of-early-drug-discovery-programs-investment-from-takeda-astellas-and-sumitomo-mitsui-banking-302270829.html#:~:text=In%2DLanguage%20News-,Joint%20Venture%20Company%20Established%20for%20Incubation%20of%20Early%20Drug%20Discovery,Astellas%20and%20Sumitomo%20Mitsui%20Banking&text=Ciconia%20Bioventures%20Inc.

PR NEWSWIRE
08 Oct 2024

ABOUT THIS PAGE

Contact Sumitomo and get a quotation

Sumitomo is a supplier offers 4 products (APIs, Excipients or Intermediates).

Find a price of Droxidopa bulk offered by Sumitomo

Find a price of Lurasidone Hydrochloride bulk offered by Sumitomo

Find a price of Meropenem bulk offered by Sumitomo

Find a price of Zonisamide bulk offered by Sumitomo

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty